Effect of bevacizumab plus paclitaxel and carboplatin regimen on prognostic survival of ovarian cancer patients.

Qingling Jiang,Hong Qian, Lin Mei, Qi Sun,Xiaofei Cheng,Wenzhi Huang,Minglin Xia,Jia Shao,Jidong Wang

American journal of translational research（2022）

引用 0|浏览1

暂无评分

摘要

Combined treatment of bevacizumab plus paclitaxel and carboplatin improved the treatment outcome and reduced the levels of CA199, CEA and CA242 in OC without increasing the incidence of adverse events.

查看译文

关键词

Bevacizumab,carboplatin,ovarian cancer,paclitaxel

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要